Healthcare / Diagnostics & ResearchUpdated 2026-05-10 22:07 UTC

TWST stock hub

Twist Bioscience Corporation has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TWSTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.5B

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TWST

In the news

Latest news · TWST

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-18.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-14.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TWST market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001581280
Company name	Twist Bioscience Corporation
Country	United States
Country code	US
Cusip	90184D100
Employees	979
Employees Change	56%
Employees Change Percent	6.07
Enterprise value	$3.5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Diagnostics & Research
IPO Date	2018-10-31
Isin	US90184D1000
Last refreshed	2026-05-10
Market cap	$3.5B
Market cap category	Mid-Cap
Price	$56.85
Price currency	USD
Rev Per Employee	418,262.51x
Sector	Healthcare
Sic	2836
Symbol	TWST
Website	https://www.twistbioscience.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.3%
EV Sales Forward	7.23x
EV/Sales	8.5x
FCF yield	-2.68%
P/B ratio	7.76x
P/S ratio	8.65x
PS Forward	7.36x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-32.14%
EBITDA Margin	-26.82%
Gross margin	52.07%
Gross Profit	$213.2M
Gross Profit Growth	31.32%
Gross Profit Growth Q	24.1%
Gross Profit Growth3 Y	31.31%
Gross Profit Growth5 Y	38.55%
Net Income	$-81.3M
Net Income Growth Years	1%
Pretax Margin	-19.67%
Profit Margin	-19.85%
Profit Per Employee	$-83,019
ROA	-12.94
Roa5y	-16.07
ROCE	-23.66
ROE	-18.16
Roe5y	-29.69
ROIC	-14.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	73.49%
Cagr3y	63.98%
Cagr5y	-13.4%
EPS Growth Years	1
Revenue Growth	17.78x
Revenue Growth Q	19.31x
Revenue Growth Quarters	30x
Revenue Growth Years	9x
Revenue Growth3 Y	21.58x
Revenue Growth5 Y	29.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.64
Assets	$676.2M
Cash	$171.7M
Current Assets	$323.4M
Current Liabilities	$120M
Debt	$110.8M
Debt Equity	$0.24
Equity	$455.1M
Liabilities	$221.1M
Long Term Assets	$352.8M
Long Term Liabilities	$101.1M
Net Cash	$60.8M
Net Cash By Market Cap	$1.72
Net Cash Growth	-62.42%
Net Debt Equity	$-0.13
Tangible Book Value	$359.9M
Tangible Book Value Per Share	$5.79
WACC	15.99

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.7
Inventory Turnover	7.22
Net Working Capital	$42.2M
Quick ratio	2.04
Working Capital	$203.5M
Working Capital Turnover	$1.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3.23%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	73.43%
200-day SMA	38.01
3Y total return	341.04%
50-day SMA	51.56
50-day SMA vs 200-day SMA	50over200
5Y total return	-51.3%
All Time High	214.1
All Time High Change	-73.44%
All Time High Date	2021-01-21
All Time Low	11.46
All Time Low Change	396.07%
All Time Low Date	2023-05-02
ATR	3.51
Beta	2.23
Beta1y	1.53
Beta2y	2.01
Ch YTD	79.22
High	59
High52	66.06
High52 Date	2026-04-22
High52ch	-13.94%
Low	56
Low52	23.3
Low52 Date	2025-11-14
Low52ch	143.99%
Ma50ch	10.27%
Premarket Change Percent	1.26
Premarket Price	$59.28
Premarket Volume	929
Price vs 200-day SMA	49.56%
RSI	51.52
RSI Monthly	61.7
RSI Weekly	66.68
Sharpe ratio	1.1x
Sortino ratio	1.82
Total Return	-3.23%
Tr YTD	79.22
Tr1m	13.43%
Tr1w	-5.88%
Tr3m	15.46%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.53
Earnings Revenue Estimate	107,696,704x
Earnings Revenue Estimate Growth	16.06x
Operating Income	$-131.6M
Operating margin	-32.14
Price target	$53.44
Price Target Change	$-6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	55,416,803%
Float Percent	88.99%
Shares Insiders	2.37%
Shares Institutions	107.75%
Shares Out	62,271,314
Shares Qo Q	1.02%
Shares Yo Y	3.23%
Short Float	26.21%
Short Ratio	12.19
Short Shares	23.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-159.4M
Average Volume	1,546,957.05x
Bv Per Share	7.32
CAPEX	$-39.5M
Ch1m	13.43
Ch1w	-5.88
Ch1y	73.43
Ch3m	15.46
Ch3y	341
Ch5y	-51.3
Ch6m	87.81
Change	-2.89%
Change From Open	-3.14
Close	58.54
Days Gap	0.26
Depreciation Amortization	21,777,000
Dollar Volume	61,992,082.5
Earnings Date	2026-05-04
Earnings Time	bmo
EBIT	$-131.6M
EBITDA	$-109.8M
EPS	$-1.34
F Score	3
FCF	$-95M
FCF EV Yield	-2.73x
FCF Per Share	$-1.53
Financing CF	11,836,000
Fiscal Year End	September
Founded	2,013
Goodwill	82,195,000
Income Tax	$744,000
Investing CF	-44,439,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-04
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2025-11-17
Ma150	41.29
Ma150ch	37.69%
Ma20	58.62
Ma20ch	-3.02%
Net CF	-88,095,000
Next Earnings Date	2026-08-03
Open	58.69
Optionable	Yes
Position In Range	28.33
Post Close	56.85
Postmarket Change Percent	1.06
Postmarket Price	$57.45
Ppne	181,881,000
Pre Close	58.54
Price Date	2026-05-08
Ptbv Ratio	9.84
Relative Volume	0.7x
Revenue	409,479,000x
SBC By Revenue	15.71x
Share Based Comp	64,349,000
Tax By Revenue	0.18x
Tr6m	87.81%
Us State	California
Volume	1,090,450
Z Score	3.21

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TWST pay a dividend?

Capital-return profile for this ticker.

Performance

TWST stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TWST?

Insider, institutional, and short-interest positioning.

Institutional ownership

+107.8%

Float: +89.0% of shares outstanding

Insider ownership

+2.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TWST momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.5

Neutral momentum band

Price vs 200-day MA

+49.6%

50/200-day relationship not available

Beta (5Y)

2.23

More volatile than the market

Sharpe ratio

1.10

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TWST

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TWST stock rating?

Twist Bioscience Corporation is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TWST analysis?

The full report lives at /stocks/TWST/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TWST?

The latest report frames TWST around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TWST page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.